NCT01972074View on ClinicalTrials.gov

Behavioral and Neural Response to Memantine in Adolescents With Autism Spectrum Disorder

PHASE3CompletedINTERVENTIONAL
Enrollment

84

Participants

Timeline

Start Date

February 17, 2015

Primary Completion Date

May 7, 2018

Study Completion Date

May 7, 2018

Conditions
Autism Spectrum Disorder
Interventions
DRUG

Memantine

Capsule

OTHER

Placebo

Capsule

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
collaborator

Mclean Hospital

OTHER

lead

Massachusetts General Hospital

OTHER

NCT01972074 - Behavioral and Neural Response to Memantine in Adolescents With Autism Spectrum Disorder | Biotech Hunter | Biotech Hunter